|
|
Latest Filings
|
| View
|
Form
|
|
Filer
|
Received
|
Period
|
Download / Print
|
Actions
|
     |
8-K |
|
CNS PHARMACEUTICALS, INC. |
09/18/24 |
09/12/24 |
|
|
  |
| |
8-K |
|
CNS PHARMACEUTICALS, INC. |
09/12/24 |
09/10/24 |
|
|
|
  |
10-Q |
|
CNS PHARMACEUTICALS, INC. |
08/14/24 |
06/30/24 |
|
|
|
| |
8-K |
|
CNS PHARMACEUTICALS, INC. |
08/07/24 |
08/06/24 |
|
|
|
| |
4 |
|
CORTICE BIOSCIENCES, INC. |
08/06/24 |
07/30/24 |
|
|
|
| |
3 |
|
CORTICE BIOSCIENCES, INC. |
08/06/24 |
07/29/24 |
|
|
|
| |
EFFECT |
|
CNS PHARMACEUTICALS, INC. |
08/05/24 |
|
|
|
|
| |
SC 13D |
|
CORTICE BIOSCIENCES, INC. |
08/02/24 |
|
|
|
|
| |
RW |
|
CNS PHARMACEUTICALS, INC. |
07/31/24 |
|
|
|
|
| |
424B3 |
|
CNS PHARMACEUTICALS, INC. |
07/30/24 |
|
|
|
|
|
|
|
|
|
Institutional Holders
|
|
|
Total Number of Holders
|
22
|
|
% of Shares Outstanding |
0.45%
|
|
Total Shares Held |
144,154
|
|
Total Value of Holdings |
$17,154.33
|
|
Net Activity |
124,701
|
|
|
|
|
|
Latest Company News
|
|
Date
|
|
|
|
|
|
|
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
|
|